City
Epaper

FDA authorizes first-ever breathing test for detecting COVID-19 infection

By ANI | Updated: April 16, 2022 07:10 IST

The Food and Drug Administration (FDA) authorized the first test, InspectIR COVID-19 Breathalyzer, to detect COVID-19 through the breath for emergency use.

Open in App

The Food and Drug Administration (FDA) authorized the first test, InspectIR COVID-19 Breathalyzer, to detect COVID-19 through the breath for emergency use.

The InspectIR COVID-19 Breathalyzer uses a technique called gas chromatography gas mass-spectrometry (GC-MS) to separate and identify chemical mixtures and rapidly detect five Volatile Organic Compounds (VOCs) associated with SARS-CoV-2 infection in exhaled breath. When the InspectIR COVID-19 Breathalyzer detects the presence of VOC markers of SARS-CoV-2, a presumptive (unconfirmed) positive test result is returned and should be confirmed with a molecular test, FDA informed in a statement.

The InspectIR COVID-19 Breathalyzer which is about the size of a carry-on piece of luggage is able to identify five volatile organic compounds tied to the coronavirus in a person's breath using a technique known as gas chromatography gas mass-spectrometry, delivering results within three minutes, according to the FDA, the statement reads.

The agency said that in a study of 2,409 people, which included both people with and without symptoms, the test had a 99.3 per cent specificity rate, which measures the per cent of correctly identified negative test samples.

The FDA also noted that the InspectIR COVID-19 Breathalyzer had a 91.2 per cent sensitivity rate, which measures the per cent of correctly identified positive test samples.

However, the health agency said that a molecular test should be used to confirm positive test results returned by the COVID-19 breath test.

Jeff Shuren, director of the FDA's Center for Devices and Radiological Health, in a statement, said, "Today's authorization is yet another example of the rapid innovation occurring with diagnostic tests for COVID-19," as per The Hill.

Nearly 100 of the InspectIR COVID-19 Breathalyzers, each of which the FDA said can be used to test roughly 160 samples per day, are anticipated to be made each week.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Jeff shurenfdaFood And Drug AdministrationFood products, medicinesUnited states food and drug administrationCommissioner of food and drugs administrationUsfdaUnited states' food and drug administrationUnited states food & drug administrationU.s. food and drug administration
Open in App

Related Stories

PunePune: Action to Be Taken Against Use of Calcium Carbide to Ripen Mangoes

MumbaiMumbai: FDA Seizes Medicines Worth Rs 61.95 Lakh from Ghatkopar-Based Drug Firm

MumbaiMumbai: FDA Cracks Down on Adulterated Milk at City Entry Points; Over 1.5 Lakh Litres Inspected

NashikAdulterated Paneer in Nashik: FDA Raids Factory, Seizes 239 Kg Paneer Worth Rs 47,800 Ahead of Gudi Padwa and Eid

MaharashtraChandrapur Shops Caught Selling Fake Paneer; FDA Seizes 472 Kg of Cheese Analogue

International Realted Stories

InternationalPahalgam attack: Indian High Commission in London holds prayer meet, pays solemn tribute

InternationalIncreases in vaccine-preventable disease outbreaks threaten years of progress, warn WHO, UNICEF, Gavi

International"Shock for the world": Russian MLA Abhay Kumar Singh on Pahalgam terror attack

InternationalPresident Droupadi Murmu departs for Vatican City to attend Pope Francis' State Funeral

InternationalJoe Kasper steps down as Chief of Staff to Defence Secretary Hegseth, moves to advisory role